International Studies Validate Noninvasive Tests for Advanced Liver Scarring, Potentially Reducing Biopsies

Source Summary

Two major international studies have established the strongest evidence to date on which noninvasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH. The findings could reduce the need for liver biopsies in clinical practice.

Why it matters

Accurate noninvasive diagnostic methods could spare patients from invasive biopsy procedures while improving early detection and severity assessment of progressive liver disease.